Cogent Biosciences Inc
COGT
NASDAQ
Biotechnology
$37.93
USD
+0.62 (+1.66%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $6.51B
Volume 1.2M
Price Target
$52.00 – $55.00
USD
The 2 analysts offering 1-year price forecasts have a max estimate of $55.00 and a min estimate of $52.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$53.50
-$0.8 vs prior
Implied Upside
+41.0%
-2.0% vs prior
Analyst Covering
2
-2 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
33%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts largely agree
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
2 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
2 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Michael Schmidt | Guggenheim | Buy | Maintained | 4 days ago | Plus | Plus | Plus |
David Nierengarten | Wedbush | Buy | Reiterated | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
SRRK
Scholar Rock Holding Corp
$52.52
▼ -1.0%
CAI
Caris Life Sciences Inc
$21.80
▼ -1.7%
MIRM
Mirum Pharmaceuticals Inc
$100.64
▲ +1.9%
ERAS
Erasca Inc
$18.38
▲ +2.9%
PTCT
PTC Therapeutics Inc
$71.70
▼ -0.4%
CGON
CG Oncology Inc
$75.03
▲ +0.4%
ORKA
Oruka Therapeutics Inc
$111.04
▲ +2.7%
DNTH
Dianthus Therapeutics Inc
$115.96
▲ +5.8%